Abstract
Communication with patients in language they understand leads to greater comprehension of treatment and diagnoses but can be time consuming for clinicians. Here we sought to investigate the utility of ChatGPT to translate clinic letters into language patients understood, without loss of clinical information. Twenty-three letters from a range of specialities were translated, resulting in no loss of clinical information. Subjective analysis from patient representatives revealed significantly increased understanding of treatment and diagnoses, increased satisfaction, and a significant decrease in the requirement to seek medical assistance in understanding their content when compared to original letters written to clinicians. Overall, we conclude that ChatGPT can be used to translate clinic letters into patient friendly language, and that these letters are preferred by patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was granted by the Research Ethics Committee of Anglia Ruskin University (application number: ETH2324-2982).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
